Acetaminophen, a centrally-acting analgesic involving the periaqueductal grey.
We previously demonstrated that acetaminophen (AcAP) has to be metabolized in the brain by fatty acid amide hydrolase enzyme (FAAH) into AM404 (N-(4-hydroxyphenyl)-5Z,8Z,11Z,14Z-eicosatetraenamide) to recruit CB1 and TRPV1 receptors, responsible for its analgesic effect. However, the brain mechanisms supporting AcAP-induced analgesia remain unknown. The effects of AcAP on brain function of rat was determined by functional magnetic resonance imaging. Periaqueductal grey (PAG) neurotransmitters were measured using in vivo 1 H-NRM and microdialysis. The analgesic effect of AcAP was assessed by behavioural tests and challenged with different inhibitors systematically administered or micro-injected in the PAG. AcAP decreased the connectivity of major brain structures involved in pain processing (insula, somatosensory cortex, amygdala, hypothalamus and the PAG). This effect was particularly prominent in PAG, where AcAP via AM404 (i) modulates neuronal activity and functional connectivity, (ii) promotes GABA and glutamate release, and (iii) activates a TRPV1-mGluR5-PLC-DAGL-CB1 signaling cascade supporting its analgesic effect. The deciphering of the modus operandi of AcAP paves the way for pharmacological innovations to improve the pharmacopoeia of analgesics.